Exploring the burden of short-term CHOP chemotherapy adverse events in post-transplant lymphoproliferative disease: a comprehensive literature review in lymphoma patients.
Crystal WatsonArie BarlevJodie WorrallSteve DuffRachel BeckermanPublished in: Journal of drug assessment (2020)
Short-term AEs from CHOP in the lymphoma population were associated with substantial humanistic and economic burden.